Poly Medicure Ltd

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Poly Medicure Ltd demonstrated robust intraday strength on 4 Mar 2026, surging to a day’s high of Rs 1,407.8, marking a 7.77% increase from its previous close. This performance outpaced the broader Healthcare Services sector and the Sensex, reflecting notable trading momentum amid a mixed market backdrop.

Poly Medicure Ltd, a key player in the Healthcare Services sector, touched a fresh 52-week low of Rs.1210.35 today, marking a significant decline in its stock price amid ongoing challenges in both near-term and long-term performance metrics.

Poly Medicure Ltd’s shares declined to a fresh 52-week low of Rs.1240 on 27 Feb 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The healthcare services company has witnessed a sustained fall in its share price, reflecting a combination of subdued financial performance and broader market pressures.

Poly Medicure Ltd, a key player in the Healthcare Services sector, touched a new 52-week low of Rs.1242.25 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance factors.

Poly Medicure Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Poly Medicure Ltd, a key player in the healthcare services sector, has touched a fresh 52-week low of Rs.1257.6 today, marking a significant decline amid a sustained downward trend over recent sessions. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s financial and operational metrics.

Poly Medicure Ltd’s shares declined to a fresh 52-week low of Rs 1260.75 on 13 Feb 2026, marking a significant drop amid broader sector weakness and subdued company performance metrics. The stock has been on a downward trajectory for three consecutive days, shedding 14.57% over this period and underperforming its healthcare services peers.

Poly Medicure Ltd’s shares declined to a fresh 52-week low of Rs 1358.55 on 12 Feb 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns.

Poly Medicure Ltd, a prominent player in the healthcare services sector, has seen its investment rating downgraded from Strong Sell to Sell as of 11 February 2026. This adjustment reflects deteriorating financial trends, expensive valuation metrics, and weakening technical indicators, signalling caution for investors amid a challenging market environment.

Poly Medicure Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Poly Medicure Ltd, a key player in the healthcare services sector, has reached a new 52-week low of Rs.1372 today, marking a significant decline amid a sustained downward trend over the past several sessions.

Poly Medicure Ltd, a key player in the Healthcare Services sector, has witnessed a notable shift in its valuation parameters, signalling a decline in price attractiveness despite its robust long-term returns. The company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have moved from very expensive to expensive territory, reflecting growing investor caution amid recent market volatility and a sharp share price correction.

Poly Medicure Ltd witnessed a sharp decline today, touching an intraday low of Rs 1,392.55, marking a 7.15% drop as the stock faced significant price pressure amid broader sector weakness and persistent volatility.

Poly Medicure Ltd’s stock declined sharply to a new 52-week low of Rs.1395 on 6 Feb 2026, marking a significant downturn amid broader sector weakness and company-specific financial setbacks. The stock has underperformed both its sector and the broader market over the past year, reflecting mounting concerns among investors.

Poly Medicure Ltd, a key player in the healthcare services sector, posted its December 2025 quarterly results revealing a mixed financial performance. While net sales reached an all-time high of ₹493.66 crores, the company experienced contraction in profitability metrics, signalling emerging challenges in operational efficiency and margin sustainability.